Literature DB >> 15484154

Abnormal QT prolongation and psychotropic drug therapy in psychiatric patients: significance of bradycardia-dependent QT prolongation.

Tsuneaki Sadanaga1, Fumiko Sadanaga, Hiroshi Yao, Masatoshi Fujishima.   

Abstract

Because many psychotropic drugs have electrophysiological properties similar to antiarrhythmic drugs, they might lengthen QT interval and cause torsades de pointes. Electrocardiograms were obtained in 688 psychiatric patients receiving psychotropic drugs. A QTc interval >460 ms was observed in 96 (14%) patients. To elucidate the heart rate dependence of QT prolongation, we measured QT intervals and the preceding R-R intervals at various heart rates by 24-hour Holter electrocardiogram in 97 patients. We estimated the QT intervals at the heart rates of 80 beats/min and 50 beats/min by the regression curve. A QT interval at the heart rate of 80 beats/min exceeded 400 ms in 14 (15%) patients and that at the heart rate of 50 beats/min exceeded 480 ms in additional 12 (12%) patients. Therefore, additional attention is needed for bradycardia-dependent QT prolongation even when the QT interval was not prolonged at usual heart rates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15484154     DOI: 10.1016/j.jelectrocard.2004.07.001

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  4 in total

1.  Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study.

Authors:  M Nosè; I Bighelli; M Castellazzi; G Martinotti; G Carrà; C Lucii; G Ostuzzi; F Sozzi; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2015-10-15       Impact factor: 6.892

Review 2.  Measurement and Management of QT Interval Prolongation for General Physicians.

Authors:  Praveen Indraratna; Daniel Tardo; Madeline Delves; Richard Szirt; Ben Ng
Journal:  J Gen Intern Med       Date:  2019-10-25       Impact factor: 5.128

3.  Sudden death of cardiac origin and psychotropic drugs.

Authors:  Quadiri Timour; Dominique Frassati; Jacques Descotes; Philippe Chevalier; Georges Christé; Mohamed Chahine
Journal:  Front Pharmacol       Date:  2012-05-10       Impact factor: 5.810

4.  Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010.

Authors:  Christoph Josef Spindelegger; Konstantinos Papageorgiou; Renate Grohmann; Rolf Engel; Waldemar Greil; Anastasios Konstantinidis; Marcus Willy Agelink; Stefan Bleich; Eckart Ruether; Sermin Toto; Siegfried Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.